文档介绍：: .
HIGHLIGHTS OF PRESCRIBING INFORMATIOgal drug indicated in adults for the mg/minute (,)
treatment of:
Candidemia and other forms of Candida infections (intra-abdominal ------------------------------ADVERSE REACTIONS-------------------------------
abscess and peritonitis) () Candidemia and other forms of Candida infections: Most common
Esophageal candidiasis () adverse reactions (15%) are hypokalemia, nausea, diarrhea, vomiting,
pyrexia, insomnia ()
Limitations of use: has not been studied in endocarditis, osteomyelitis and Esophageal candidiasis: Most common adverse reactions (5%) are
meningitis due to Candida or in sufficient numbers of neutropenic patients diarrhea, pyrexia, anemia, headache, vomiting, nausea and dyspepsia
() ()
----------------------DOSAGE AND ADMINISTRATION----------------------- To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc at
Candidemia and other forms of Candida infections: 200 mg loading 1-800-438-1985 or FDA at 1-800-FDA-1088 or
dose on Day 1, followed by 100 mg daily dose thereafter for at least 14
days after the last positive culture () -----------------------USE IN SPECIFIC POPULATIONS------------------------
Esophageal candidiasis: 100 mg loading